State Medicaid agencies can improve D-SNP financial transparency and reward those D-SNPs that provide the best value to ...
We recently published a list of 10 Tech Stocks with High Upside Potential. In this article, we are going to take a look at ...
3d
Hosted on MSNSNPS Plunges 21% in a Year: Should You Hold or Fold the Stock?Synopsys SNPS shares plunged 20.8% over the past year, underperforming the Zacks Computer - Software industry, Zacks Computer ...
Synopsys (SNPS), a company that provides software for designing computer chips, is planning to sell around $10 billion worth of bonds as early ...
Synopsys (NASDAQ:SNPS – Free Report) had its price target decreased by Piper Sandler from $655.00 to $653.00 in a report released on Thursday,Benzinga reports. Piper Sandler currently has an ...
This post was written by Luke Carberry Mogan. SNPS' first-quarter performance is likely to have benefited from the rising adoption of EDA, IP solutions and Synopsys.ai platform. Get a deeper ...
In a report released yesterday, Clarke Jeffries from Piper Sandler maintained a Buy rating on Synopsys (SNPS – Research Report), with a price ...
Despite a dip in overall revenue, Synopsys Inc (SNPS) sees growth in Design Automation and advances in AI-driven solutions.
Synopsys SNPS delivered better-than-expected first-quarter fiscal 2025 results. The company reported non-GAAP earnings of $3.03 per share for the first quarter, surpassing the Zacks Consensus ...
A comprehensive national study examining dementia patient outcomes for Medicare Advantage beneficiaries with Alzheimer's disease and related dementias (ADRD) uncovered key insights into healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results